arrow
S

Sebastiaan Remmers

Erasmus MC Cancer Institute and University Medical Center Rotterdam
H指数:22
被引数:1,429

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of Causal and Noncausal Components of Screening on Prostate Cancer Mortality: A Mediation Analysis from the Dutch, Finnish, and Swedish Centers of the European Randomized Study of Screening for Prostate Cancer

筛查的因果和非因果成分对前列腺癌死亡率的影响:一项来自欧洲前列腺癌筛查随机研究荷兰、芬兰和瑞典中心的介导分析

2026-01-070
OAAI
Treatment-Free Survival and the Pattern of Follow-Up Treatments After Curative Prostate Cancer Treatment, a Real-World Analysis of Big Data from Electronic Health Records from a Tertiary Center

根治性前列腺癌治疗后的无治疗生存期及随访治疗模式:一项基于三级中心电子健康记录大数据的真实世界分析

2026-01-040
OAAI
Rethinking Gleason pattern quantification in predicting metastasis: results of 20 years of follow-up in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer

重新思考Gleason模式量化在预测转移中的作用:欧洲前列腺癌筛查随机研究鹿特丹分部的20年随访结果

2025-11-010
OAAI
Real-world Evidence on Baseline Characteristics and Treatment in Metastatic Hormone-sensitive Prostate Cancer: Findings from the PIONEER 2.0 Big Data Investigation Group

真实世界证据:转移性激素敏感性前列腺癌的基线特征和治疗——PIONEER 2.0大数据调查组的研究发现

2025-10-070
OAAI
Observational Health Data Analysis of the Cardiovascular Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER Platform

基于PIONEER平台的大数据分析:转移性激素敏感性前列腺癌患者系统性治疗心血管不良事件的真实世界数据研究

2025-10-030
PRE
Prognostic surgical factors related to short term urethroplasty complications after Tubularized Incised urethral Plate Urethroplasty in distal- and mid-type hypospadias in the Dutch Hypospadias Study

与荷兰尿道上裂研究(Dutch Hypospadias Study)中远端型和中部型尿道上裂行管化切开尿道板尿道成形术(Tubularized Incised urethral Plate Urethroplasty)后短期尿道成形术并发症相关的预后手术因素

2025-10-010
OAAI
Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment

1级前列腺癌主动监测的长期结果以及使用MRI对过度治疗的影响

2025-04-010
OAAI
An Overview of Patient-reported Outcomes for Men with Prostate Cancer: Results from the PIONEER Consortium
2025-01-010
OAAI
Assessing the Cause of Death for Men with Prostate Cancer Using Official Mortality Statistics or a Dedicated Cause of Death Committee: Results from 30-year ERSPC Rotterdam Data

使用官方死亡率统计数据或死亡委员会的专门原因评估前列腺癌男性的死亡原因: 来自ERSPC鹿特丹30年数据的结果

2025-01-010
PRE
Follow-up on patients with initial negative mpMRI target and systematic biopsy for PI-RADS ≥ 3 lesions - an EAU-YAU study enhancing prostate cancer detection
2024-11-053
PRE
Reducing Overtreatment of Prostate Cancer Patients: Revisiting the European Association of Urology Pretreatment Risk Group Classification Using Long-term Follow-up Data from the European Randomized Study of Screening for Prostate Cancer Rotterdam

减少前列腺癌患者的过度治疗:利用欧洲前列腺癌筛查随机研究鹿特丹队列的长期随访数据重新评估欧洲泌尿外科学会术前风险分组分类

2024-11-010
OAAI
From Screening to Mortality Reduction: An Overview of Empirical Data on the Patient Journey in European Randomized Study of Screening for Prostate Cancer Rotterdam After 21 Years of Follow-up and a Reflection on Quality of Life

从筛查到降低死亡率: 欧洲前列腺癌筛查随机研究的经验数据概述鹿特丹经过21年的随访和生活质量的反思

2024-08-011
OA
Understanding the Barriers to Prostate Cancer Population-Based Early Detection Programs: The PRAISE-U BEST Survey
2024-07-150
OA
Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical Registry

主动监测前列腺癌是否已变得更安全?全球临床登记研究的经验教训

2024-07-010
OAAI